Jump to navigation Jump to search

WikiDoc Resources for Syringomyelia


Most recent articles on Syringomyelia

Most cited articles on Syringomyelia

Review articles on Syringomyelia

Articles on Syringomyelia in N Eng J Med, Lancet, BMJ


Powerpoint slides on Syringomyelia

Images of Syringomyelia

Photos of Syringomyelia

Podcasts & MP3s on Syringomyelia

Videos on Syringomyelia

Evidence Based Medicine

Cochrane Collaboration on Syringomyelia

Bandolier on Syringomyelia

TRIP on Syringomyelia

Clinical Trials

Ongoing Trials on Syringomyelia at Clinical

Trial results on Syringomyelia

Clinical Trials on Syringomyelia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Syringomyelia

NICE Guidance on Syringomyelia


FDA on Syringomyelia

CDC on Syringomyelia


Books on Syringomyelia


Syringomyelia in the news

Be alerted to news on Syringomyelia

News trends on Syringomyelia


Blogs on Syringomyelia


Definitions of Syringomyelia

Patient Resources / Community

Patient resources on Syringomyelia

Discussion groups on Syringomyelia

Patient Handouts on Syringomyelia

Directions to Hospitals Treating Syringomyelia

Risk calculators and risk factors for Syringomyelia

Healthcare Provider Resources

Symptoms of Syringomyelia

Causes & Risk Factors for Syringomyelia

Diagnostic studies for Syringomyelia

Treatment of Syringomyelia

Continuing Medical Education (CME)

CME Programs on Syringomyelia


Syringomyelia en Espanol

Syringomyelia en Francais


Syringomyelia in the Marketplace

Patents on Syringomyelia

Experimental / Informatics

List of terms related to Syringomyelia

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Tarek Nafee, M.D. [2] Aysha Aslam, M.B.B.S[3] Eman Alademi, M.D.[4]


Syringomyelia is a spinal cord cavitation, which is a central dilation due to cystic degradation expands and destroyed the spinal cord. Caused by an injury, tumors or congenital malformation like hernia. The damage can Effect the brain and nerves, that leade to Bilateral loss of pain and temperature sensation in upper extremities. weakness, stiffness, hyperReflexives in lower extremities with hyposcoliosis. Each patient experiences a different combination of symptoms. These symptoms typically vary depending on the extent and, often more critically, on the location of the syrinx within the spinal cord.

Historical Perspective

  • In the 16th century, Estienne, a French anatomist, observed spinal cord cavitation for the first time.[1][2]
  • In 1545, Stephanus reported a case of spinal cord dilatation in one of his patients.[1][2]
  • In 1688, Brunner reported a liquor filled cavity with hydrocephalus in a pediatric case.[1][2]
  • In 1824, Olivier d'Angers coined the term syringomyelia.[1][2]
  • Also in 1824, Schuppel defined the fluid in the syrinx as a hydromyelia and proposed the pathogenesis as the persistence of the fetal central canal.[1][2]
  • In 1882, Otto von Kohler and Fredrich Schultz defined the clinical syndrome of syringomyelia.[1][2]
  • Between 1883 to 1891, Cleland and Hans Chiari associated syrinx formation with hyind brain herniation in what was subsequently named Chiari malformations types I to III. [1][2]
  • In 1959, Gardner described the waterhammer theory for pathogenesis of syringomyelia.[3]
  • In 1972, Ball and Dyan described the cavitation of the perivascular space as the source of syrinx formation.[4]
  • In 1980, Williams described the "suck and slosh" theory of syrinx formation.[5]
  • In 1994, Oldfield describes the piston effect of Chiari I malformation resulting in syringomyelia.[6]
  • In 2003, the Cisterna magna theory aimed to harmonize the Gardner, Williams, Oldfield and Ball&Dyan theories with neural imaging findings to propose an objective proposal of the pathogenesis of syringomyelia.[7]


Syringomyelia may be classified in various ways according to the anatomical features of the syrinx, or according to the underlying etiology of the disease.[8]

By Anatomy

Syringomyelia may be classified according to the anatomical description of the lesion (syrinx) as follows:[8]

  • Communicating vs. Non-communicating:
  • Intracannalicular vs. Extracannalicular:
    • Intracannalicular synringomyelia originates within the central canal of the spinal cord.
    • Extracannalicular syringomyelia originates within the spinal cord parenchyma.

By Etiology

Syringomyelia may be classified according to the underlying etiology or associated condition as follows:[9][10][11]

  • Congenital Malformations
  • Post-infectious
  • Post-traumatic
  • Post-inflammatory
  • Neoplastic



The exact pathogenesis of syringomyelia remains unknown. Several theories have been postulated about the development of a syrinx in the spinal cord. The underlying mechanisms of the disease involves disruption of CNS flow, subsequent formation of a syrinx, and enlargement of the lesion to impinge on the surrounding nerve fibers resulting in a symptomatic presentation.

1. Disruption of CSF Flow
Disruption of CSF flow may occur secondary to any of the following conditions:
  • Congenital craniocervical abnormalities obstructing CSF flow from the ventricles to the central canal (e.g., arnold chiari malformation, scoliosis)
  • Tumor or arachnoid cyst exhibiting a mass effect on the spinal cord
  • Sequelae of spinal cord trauma results in abnormal obstruction of the central canal
  • Sequelae of meningitis resulting in inflammation of the spinal cord meninges
  • Sequelae of inflammatory conditions such as sarcoidosis, multiple sclerosis, seronegative spondyloarthropathies
2. Syrinx formation
The pathogenesis of a syrinx is largely unknown. There are five primary theories of intra and extra cannilicular
  • Gardner's hydrodynamic theory: Blockage of the foramen of Magendie at the obex results in a pulsatile "water-hammer" effect of the mass lesion on the spinal cord CSF. This pressure differential results in extravasation of fluid into the perivascular and extracellular spaces.[7][12][3]
  • William's theory: Increased intracranial pressure combined with decreased subarachnoid spinal pressure results in a "vaccuum-like" effect which further herniates the cerebellar tonsils through the foramen magnum. This results in sloshing of the subarachnoid CSF and causes extravasation of the CSF into the spinal cord parenchyma, thus creating a syrinx.[7][5]
  • Ball & Dyan theory: With the CSF pressure difference created by the lesion, fluid moves, collects, and expands within Robin Virchow's perivascular space.[4]
  • Oldfield's theory: The pulsatile waves of the CSF which occur during systole result in increased ICP. This increased pressure herniates the cerebellum to obstruct the subarachnoid space at the level of the foramen magnum. This pulsatile fluid wave against the surface of the spinal cord results in extravasation of fluid into the parenchyma and creates a syrinx.[6]
  • Cisterna Magna theory: This theory claims that the fluid storage capacity of the cisterna magna is the primary shock absorber of the CNS that allows the spinal cord parenchyma to remain protected from increases in intracranial pressure. Mass effect of any lesion "stiffens" the cisterna magna and results in decreased compliance of the space and increased transferrance of pressure to the spinal cord. This results in extravasation of fluid to the spinal cord parenchyma.[7]
3. Development of symptoms
Once the syrinx enlarges enough to impinge on the surrounding spinal cord segments, symptoms related to the affected nerve fibers will develop due to the mass effect of the syrinx itself.


There is no genetic predilection for the development of syringomyelia. However, Chiari malformations which are the primary cause of syringomyelia have demonstrated a strong familial and genomic association.[13][14][15][16][17][18]


The most common cause of syringomyelia is Chiari I malformation[19]. Other causes of syringomyelia may include:

Common Causes

Less Common Causes

Differentiating Syringomyelia from other diseases

Syringomyelia must be differentiated from other diseases which cause gait abnormalities, sensory and motor deficit, chronic pain syndromes, urinary and fecal incontinence, and cranial nerve palsies such as:[37][38][39][40][41]

Risk Factors

  The main risk factors associated with the development of syringomyelia are based on the underlying causes:


There is no recommended screening for syringomyelia.

Epidemiology and Demographics


  • More than 25% of patients with spinal cord injury progress to develop syringomyelia.[47]


Syringomyelia has a prevalence estimated at 8.4 cases per 100,000 people,[48] or about 21,000 Americans, with symptoms usually beginning in young adulthood.

Natural History, Complications, and Prognosis

Natural History

The essential Course of disease in Syringomyelia is temperamental. Without treatment, syringomyelia may progress to develop the worsening of neurological deficit in cases of obstructive lesions. However, the disease has a slower progression in cases of mild disease.[49][50][51]


Complications that can develop as a result of syringomyelia are:[36][52][53][54][55][56][57][58][59][60][61]


The prognosis of syringomyelia varies depending on factors such as cause, extent of neurological damage, presence of complications, and general health status of patient before undergoing surgical treatment.[62][63][64]

  • Patients with mild neurological deficit may respond better to surgical management.
  • Early management of syringomyelia in cases of trauma is associated with decreased morbidity.
  • The symptoms of 80% of patients usually end due to their response to surgical treatment, as well a mild cure.
  • 20% of patients gets worse despite treatment in cases of advanced disease.
  • Recurrence is not uncommon in syringomyelia.

History and Symptoms

Specific areas of focus when obtaining the history such as onset, duration and progression of symptoms; history of trauma; associated conditions like multiple sclerosis, transverse myelitis, amyotrophic lateral sclerosis, sarcoidosis, congenital malformation, infection such as meningitis or neoplasia (ependymoma, meningioma, hemangioblastoma) may help diagnosing syringomyelia. Symptoms depends on the anatomical site of spinal cord involved.[65][66][67][68][69][70]

Anatomical site Early symptoms Late symptoms
  • Inability to feel hot or cold
  • Decreased ability to feel pain sensation
  • Increased or decreased sweating
  • Muscle weakness ++
  • Shoulder joint pain, swelling and loss of function
  • Muscle paralysis
  • Loss of all sensations in hands, forearm, arm and upper back
  • Headaches with coughing or straining
  • Decreased to absent temperature sensation in trunk region
  • Abnormal pain sensation
  • Muscle weakness
  • Abnormal sweating
  • Muscle paralysis
  • Loss of pain and temperature sensation
  • Lower limb muscle weakness
  • Decreased to absent temperature sensation
  • Abnormal pain sensation
  • Joint sweling, pain and redness (charcot joints)
  • Loss of vibration, position sense and two point discrimination(recurrent falls)
  • Failure to maintain balance
  • Absent pain and temperature sensation
  • Muscle paralysis
  • Impaired ambulation
  • Bladder or bladder dysfunction
  • Sexual dysfunction (erectile dysfunction)
  • Tingling and numbness in foot or anogenital region
  • Muscle weakness ++
  • Loss of penile erection
  • Loss of ankle plantar flexion(S1)
  • Urinary or fecal incontinence
  • Loss of temperature and pain sensation in foot and perineum

Physical Examination

The following includes how syringomyelia might be revealed :[71][72][73][74][75][76]

Anatomical site Physical examination
  • Anhydrosis, miosis and ptosis (Horner's syndrome)
  • Loss of temperature and pain sensation in cervical dermatomes
  • Claw hand
  • Decreased muscle strength in hands, arms and shoulders
  • Decreased to absent deep tendon reflexes in upper limb
  • Muscle atrophy of hands, arms and shoulders
  • Tenderness, erythema, swelling and joint resorption (charcot joints)
  • Scoliosis
  • Decreased to absent pain and temperature sensation in thoracic dermatomes
  • Muscle atrophy ++
  • Absent superficial abdominal reflexes

Imaging Findings

Imaging studies that may help diagnose syringomyelia, its cause and complications include:[77][78][79]


Spinal MRI may help to diagnose and follow up syringomyelia. It is characterized by the following findings:[77][80][81][82][83]


Syringomyelia may be diagnosed as an incidental finding on CT scan. However, delayed CT scan may have a diagnostic importance in early cases of syringomyelia without clinical manifestaions.[84][85] Metrizimed CT scan using non-ionic contrast may be used to identify a syrinx in postinflammatory conditions (postinfectious and posthemorrhagic arachnoiditis).[86][87] In addition, computed axial tomography (CT) scans of a patient's head may reveal the presence of tumors and other abnormalities such as hydrocephalus.

X ray

There are no specific X ray findings associated with syringomyelia.


Myelogram is rarely used to diagnose syringomyelia. It uses a contrast material combined with x ray or CT to image spinal cord in case of syringomyelia. However, CT metrimised myelography is more sensitive to diagnose syringomyelia as compared to conventional myelography.[87][88]

Other Diagnostic Studies


EMG findings of syringomyelia include increased excitability of spinal motor neurons. However, the findings are non specific and does not hold diagnostic importance in case of syringomyelia.[89][90]

Lumbar Puncture

Role of lumbar puncture in syringomyelia is controversial since it may result in herniation in cases of Chiari malformation. However, it may be used by some clinicians as a diagnostic tool to look for CSF pressure and signs of inflammation based on individual patient assessment.[67]

Medical Therapy

Drugs have no curative value as a treatment for syringomyelia. The role of medical therapy in management of syringomyelia is for treatment of underlying conditions or management of associated symptoms.

Treatment of Underlying Conditions

Radiation and chemotherapy may be utilized for management of an underlying spinal cord tumor. Antibiotics may be used to treat an underlying infection (meningitis or encephalitis).

Management of Symptoms

In the absence of symptoms, syringomyelia is usually not treated. In addition, a physician may recommend not treating the condition in patients of advanced age or in cases where there is no progression of symptoms. Whether treated or not, many patients will be told to avoid activities that involve straining.


Surgery is not always required for syringomyelia. Indications for surgical management of syringomyelia include the following:[92][93]

  • Progressive neurological deterioration and worsening of symptoms
  • Presence of tumor causing obstruction
  • Congenital malformation(Chiari malformation)
  • Traumatic injury to spinal cord

Surgical options used to treat syringomyelia include:[94][95]

Posterior fossa decompression

  • Usually performed in Chiari malformation patients to expand the size of the posterior fossa and reverse tonsillar herniation resulting in relief of the obstructive lesion.[93][96]
  • This procedure may be combined with shunt, creating a large subarachanoid cistern to drain the syrinx or in conjunction with duroplasty in which dura is opened after bony removal of posterior occiput and posterior arch of C1 vertebra and a graft is sewed to dura effectively creating extra space in posterior fossa.[96][97]
  • Another procedure used along with posterior fossa decompression and duraplasty to help relieve obstruction is tonsillar resection or shrinkage.[98][99]

Shunt formation

Shunts are placed in order to drain the syrinx and alleviate symptoms such as headache and chronic pain syndromes. The choice of shunt is determined by the neurosurgeon; however, the following types of shunts may be performed:[97][100][101]

Ventriculoperitoneal shunt

  • Performed in patients with communicating syrinxes with hydrocephalus due to increased ventricular pressure.
  • This surgery is more commonly associated with Chiari II malformations

Syringosubarachnoid shunt

  • Performed more commonly in non-communicating syrinxes and is effective in rapidly reducing the size of the syrinx.
  • This shunt drains the syrinx into the subarachnoid space, and the CSF is subsequently reabsorbed by the arachnoid villi.

Syringoperitoneal shunt

  • Drainage of syrinx into the peritoneal cavity.

Removal of obstruction

  • In cases of tumors or arachnoid cysts as the underlying cause of the obstructive precursor lesion to syrinx formation, removal of said mass lesion may reverse the symptoms and reduce syrinx size.[102]

Surgical untethering and expansive duraplasty

  • Performed in post-traumatic syringomyelia.[67]
  • This procedure involves establishing access to the spinal cord at the level of the injury, laminectomy, lysis of adhesions, entry into spinal cord at the site of syrinx and drainage of the syrinx into said space.[67]
  • Duroplasty is usually performed following this procedure, for regional structural support.[67]

Neuroendoscopic surgery

  • Novel endoscopic procedure used for chiari malformation and syrinx drainage[103][104][105]
  • Minimally invasive
  • Fast recovery
  • Fewer complications


Primary Prevention

There are no primary preventive measures associated with syringomyelia.

Secondary Prevention


  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Klekamp J (2002). "The pathophysiology of syringomyelia - historical overview and current concept". Acta Neurochir (Wien). 144 (7): 649–64. doi:10.1007/s00701-002-0944-3. PMID 12181698.
  2. 2.0 2.1 2.2 2.3 2.4 2.5 2.6 Walusinski O (2012). "History of the Emergence and Recognition of Syringomyelia in the 19th Century". Vesalius. 18 (1): 18–29. PMID 26591071.
  3. 3.0 3.1 GARDNER WJ, ANGEL J (1958). "The cause of syringomyelia and its surgical treatment". Cleve Clin Q. 25 (1): 4–8. PMID 13500572.
  4. 4.0 4.1 Ball MJ, Dayan AD (1972). "Pathogenesis of syringomyelia". Lancet. 2 (7781): 799–801. PMID 4116236.
  5. 5.0 5.1 Williams B (1980). "On the pathogenesis of syringomyelia". Journal of Royal Society of Medicine. 73 (11): 798–806. Unknown parameter |pmcid= ignored (|pmc= suggested) (help)
  6. 6.0 6.1 Oldfield EH, Muraszko K, Shawker TH, Patronas NJ (1994). "Pathophysiology of syringomyelia associated with Chiari I malformation of the cerebellar tonsils. Implications for diagnosis and treatment". J Neurosurg. 80 (1): 3–15. doi:10.3171/jns.1994.80.1.0003. PMID 8271018.
  7. 7.0 7.1 7.2 7.3 Chang HS, Nakagawa H (2003). "Hypothesis on the pathophysiology of syringomyelia based on simulation of cerebrospinal fluid dynamics". J Neurol Neurosurg Psychiatry. 74 (3): 344–7. PMC 1738338. PMID 12588922.
  8. 8.0 8.1 Milhorat TH (2000). "Classification of syringomyelia". Neurosurg Focus. 8 (3): E1. doi:10.3171/foc.2000.8.3.1. PMID 16676921.
  9. Larner AJ, Muqit MM, Glickman S (2002). "Concurrent syrinx and inflammatory central nervous system disease detected by magnetic resonance imaging: an illustrative case and review of the literature". Medicine (Baltimore). 81 (1): 41–50. PMID 11807404.
  10. Laxton AW, Perrin RG (2006). "Cordectomy for the treatment of posttraumatic syringomyelia. Report of four cases and review of the literature". J Neurosurg Spine. 4 (2): 174–8. doi:10.3171/spi.2006.4.2.174. PMID 16506486.
  11. Batzdorf U (2000). "Primary spinal syringomyelia: a personal perspective". Neurosurg Focus. 8 (3): E7. PMID 16676930.
  12. Pillay PK, Awad IA, Hahn JF (1992). "Gardner's hydrodynamic theory of syringomyelia revisited". Cleve Clin J Med. 59 (4): 373–80. PMID 1525970.
  13. Boyles AL, Enterline DS, Hammock PH, Siegel DG, Slifer SH, Mehltretter L; et al. (2006). "Phenotypic definition of Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15". Am J Med Genet A. 140 (24): 2776–85. doi:10.1002/ajmg.a.31546. PMID 17103432.
  14. Milhorat TH, Chou MW, Trinidad EM, Kula RW, Mandell M, Wolpert C; et al. (1999). "Chiari I malformation redefined: clinical and radiographic findings for 364 symptomatic patients". Neurosurgery. 44 (5): 1005–17. PMID 10232534.
  15. Speer MC, Enterline DS, Mehltretter L, Hammock P, Joseph J, Dickerson M; et al. (2003). "Review Article: Chiari Type I Malformation with or Without Syringomyelia: Prevalence and Genetics". J Genet Couns. 12 (4): 297–311. doi:10.1023/A:1023948921381. PMID 26141174.
  16. Markunas CA, Tubbs RS, Moftakhar R, Ashley-Koch AE, Gregory SG, Oakes WJ; et al. (2012). "Clinical, radiological, and genetic similarities between patients with Chiari Type I and Type 0 malformations". J Neurosurg Pediatr. 9 (4): 372–8. doi:10.3171/2011.12.PEDS11113. PMC 3678957. PMID 22462700.
  17. Stovner LJ, Bergan U, Nilsen G, Sjaastad O (1993). "Posterior cranial fossa dimensions in the Chiari I malformation: relation to pathogenesis and clinical presentation". Neuroradiology. 35 (2): 113–8. PMID 8433785.
  18. Cavender RK, Schmidt JH (1995). "Tonsillar ectopia and Chiari malformations: monozygotic triplets. Case report". J Neurosurg. 82 (3): 497–500. doi:10.3171/jns.1995.82.3.0497. PMID 7861232.
  19. 19.0 19.1 19.2 Carlson MD, Muraszko KM (2003). "Chiari I malformation with syrinx". Pediatr Neurol. 29 (2): 167–9. PMID 14580664.
  20. Williams B (1990). "Syringomyelia". Neurosurg Clin N Am. 1 (3): 653–85. PMID 2136163.
  21. 21.0 21.1 Ozerdemoglu RA, Denis F, Transfeldt EE (2003). "Scoliosis associated with syringomyelia: clinical and radiologic correlation". Spine (Phila Pa 1976). 28 (13): 1410–7. doi:10.1097/01.BRS.0000067117.07325.86. PMID 12838099.
  22. Shankar P, Zamora C, Castillo M (2016). "Congenital malformations of the brain and spine". Handb Clin Neurol. 136: 1121–37. doi:10.1016/B978-0-444-53486-6.00058-2. PMID 27430461.
  23. Agrawal A, Shetty MS, Pandit L, Shetty L, Srikrishna U (2007). "Post-traumatic syringomyelia". Indian J Orthop. 41 (4): 398–400. doi:10.4103/0019-5413.37006. PMC 2989527. PMID 21139799.
  24. Nardone R, Alessandrini F, Tezzon F (2003). "Syringomyelia following Listeria meningoencephalitis: report of a case". Neurol Sci. 24 (1): 40–3. doi:10.1007/s100720300021. PMID 12754657.
  25. Caplan LR, Norohna AB, Amico LL (1990). "Syringomyelia and arachnoiditis". J Neurol Neurosurg Psychiatry. 53 (2): 106–13. PMC 487945. PMID 2313296.
  26. Joshi VP, Valsangkar A, Nivargi S, Vora N, Dekhne A, Agrawal A (2013). "Giant posterior fossa arachnoid cyst causing tonsillar herniation and cervical syringomyelia". J Craniovertebr Junction Spine. 4 (1): 43–5. doi:10.4103/0974-8237.121627. PMC 3872663. PMID 24381458.
  27. Na JH, Kim HS, Eoh W, Kim JH, Kim JS, Kim ES (2007). "Spinal cord hemangioblastoma : diagnosis and clinical outcome after surgical treatment". J Korean Neurosurg Soc. 42 (6): 436–40. doi:10.3340/jkns.2007.42.6.436. PMC 2588179. PMID 19096585.
  28. Gluf WM, Dailey AT (2014). "Hemorrhagic intramedullary hemangioblastoma of the cervical spinal cord presenting with acute-onset quadriparesis: case report and review of the literature". J Spinal Cord Med. 37 (6): 791–4. doi:10.1179/2045772314Y.0000000210. PMC 4231969. PMID 25029412.
  29. Mock A, Levi AD, Levi A, Drake JM (1990). "Spinal hemangioblastoma, syrinx, and hydrocephalus in a two-year-old child". Neurosurgery. 27 (5): 799–802. PMID 2259411.
  30. 30.0 30.1 Ravaglia S, Bogdanov EI, Pichiecchio A, Bergamaschi R, Moglia A, Mikhaylov IM (2007). "Pathogenetic role of myelitis for syringomyelia". Clin Neurol Neurosurg. 109 (6): 541–6. doi:10.1016/j.clineuro.2007.03.007. PMID 17467892.
  31. Markh A, Wainapel S (2016). "Transverse Myelitis and Syrinx Formation Caused by Varicella-Zoster Infection". Am J Phys Med Rehabil. 95 (1): e12–3. doi:10.1097/PHM.0000000000000391. PMID 26495810.
  32. Sotgiu S, Pugliatti M, Rosati G, Sechi GP (2001). "Which syringomyelia is truly associated with multiple sclerosis?". J Neurol Sci. 190 (1–2): 99–100. PMID 11603356.
  33. Charles JA, Berger M, Cook SD (2004). "Thoracic syringomyelia and suspected multiple sclerosis: cause and effect or coincidence?". Neurology. 63 (1): 185–6. PMID 15249639.
  34. Hamada K, Sudoh K, Fukaura H, Yanagihara T, Hamada T, Tashiro K; et al. (1990). "[An autopsy case of amyotrophic lateral sclerosis associated with cervical syringomyelia]". No To Shinkei. 42 (6): 527–31. PMID 2206638.
  35. Nakamura M, Ishii K, Watanabe K, Tsuji T, Matsumoto M, Toyama Y; et al. (2009). "Clinical significance and prognosis of idiopathic syringomyelia". J Spinal Disord Tech. 22 (5): 372–5. doi:10.1097/BSD.0b013e3181761543. PMID 19525795.
  36. 36.0 36.1 Porensky P, Muro K, Ganju A (2007). "Nontraumatic cervicothoracic syrinx as a cause of progressive neurologic dysfunction". J Spinal Cord Med. 30 (3): 276–81. PMC 2031960. PMID 17684895.
  37. van Doorn PA, Ruts L, Jacobs BC (2008). "Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome". Lancet Neurol. 7 (10): 939–50. doi:10.1016/S1474-4422(08)70215-1. PMID 18848313.
  38. Dimachkie MM, Barohn RJ (2013). "Chronic inflammatory demyelinating polyneuropathy". Curr Treat Options Neurol. 15 (3): 350–66. doi:10.1007/s11940-013-0229-6. PMC 3987657. PMID 23564314.
  39. Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA (2004). "Transverse Myelitis: pathogenesis, diagnosis and treatment". Front Biosci. 9: 1483–99. PMID 14977560.
  40. Kiefer M, Unterberg A (2012). "The differential diagnosis and treatment of normal-pressure hydrocephalus". Dtsch Arztebl Int. 109 (1–2): 15–25, quiz 26. doi:10.3238/arztebl.2012.0015. PMC 3265984. PMID 22282714.
  41. Goldenberg MM (2012). "Multiple sclerosis review". P T. 37 (3): 175–84. PMC 3351877. PMID 22605909.
  42. Guo A, Chitayat D, Blaser S, Keating S, Shannon P (2014). "Fetal syringomyelia". Acta Neuropathol Commun. 2: 91. doi:10.1186/s40478-014-0091-0. PMC 4167126. PMID 25092126.
  43. Garg RK, Malhotra HS, Gupta R (2015). "Spinal cord involvement in tuberculous meningitis". Spinal Cord. 53 (9): 649–57. doi:10.1038/sc.2015.58. PMID 25896347.
  44. Vannemreddy SS, Rowed DW, Bharatwal N (2002). "Posttraumatic syringomyelia: predisposing factors". Br J Neurosurg. 16 (3): 276–83. PMID 12201398.
  45. Ko HY, Kim W, Kim SY, Shin MJ, Cha YS, Chang JH; et al. (2012). "Factors associated with early onset post-traumatic syringomyelia". Spinal Cord. 50 (9): 695–8. doi:10.1038/sc.2012.35. PMID 22487955.
  46. Lohle PN, Wurzer HA, Hoogland PH, Seelen PJ, Go KG (1994). "The pathogenesis of syringomyelia in spinal cord ependymoma". Clin Neurol Neurosurg. 96 (4): 323–6. PMID 7889696.
  47. Brodbelt AR, Stoodley MA (2003). "Post-traumatic syringomyelia: a review". J Clin Neurosci. 10 (4): 401–8. PMID 12852875.
  48. Brewis M, Poskanzer DC, Rolland C, et al, "Neurological disease in an English city". Acta Neurologica Scand Suppl 24:1--89, 1966.
  49. Singhal A, Bowen-Roberts T, Steinbok P, Cochrane D, Byrne AT, Kerr JM (2011). "Natural history of untreated syringomyelia in pediatric patients". Neurosurg Focus. 31 (6): E13. doi:10.3171/2011.9.FOCUS11208. PMID 22133172.
  50. Mariani C, Cislaghi MG, Barbieri S, Filizzolo F, Di Palma F, Farina E; et al. (1991). "The natural history and results of surgery in 50 cases of syringomyelia". J Neurol. 238 (8): 433–8. PMID 1779249.
  51. Anderson NE, Willoughby EW, Wrightson P (1985). "The natural history and the influence of surgical treatment in syringomyelia". Acta Neurol Scand. 71 (6): 472–9. PMID 4024858.
  52. Todor DR, Mu HT, Milhorat TH (2000). "Pain and syringomyelia: a review". Neurosurg Focus. 8 (3): E11. PMID 16676923.
  53. Campos WK, Almeida de Oliveira YS, Ciampi de Andrade D, Teixeira MJ, Fonoff ET (2013). "Spinal cord stimulation for the treatment of neuropathic pain related to syringomyelia". Pain Med. 14 (5): 767–8. doi:10.1111/pme.12064. PMID 23489298.
  54. Samuelsson L, Lindell D (1995). "Scoliosis as the first sign of a cystic spinal cord lesion". Eur Spine J. 4 (5): 284–90. PMID 8581529.
  55. Whitaker C, Schoenecker PL, Lenke LG (2003). "Hyperkyphosis as an indicator of syringomyelia in idiopathic scoliosis: a case report". Spine (Phila Pa 1976). 28 (1): E16–20. doi:10.1097/01.BRS.0000038240.88287.0B. PMID 12544968.
  56. Nogués MA, Gené R (1988). "Diaphragm weakness and syringomyelia". J R Soc Med. 81 (1): 59. PMC 1291446. PMID 3343678.
  57. McCool FD, Tzelepis GE (2012). "Dysfunction of the diaphragm". N Engl J Med. 366 (10): 932–42. doi:10.1056/NEJMra1007236. PMID 22397655.
  58. Ellis C, Curzen N, Katifi H (1993). "Obstructive sleep apnoea associated with syringomyelia". Postgrad Med J. 69 (810): 308–11. PMC 2399647. PMID 8321799.
  59. Benjamin MD, Santiago J, Hebert JC, Thirion S, Ranaivojaona S, Alvarez C; et al. (2011). "[Hemihypertrophy and scoliosis revealing a Chiari 1 malformation with syringomyelia]". Arch Pediatr. 18 (11): 1210–5. doi:10.1016/j.arcped.2011.08.022. PMID 21982271.
  60. Cullen AB, Ofluoglu O, Donthineni R (2005). "Neuropathic arthropathy of the shoulder (Charcot shoulder)". MedGenMed. 7 (1): 29. PMC 1681408. PMID 16369334.
  61. Brown LK, Stacy C, Schick A, Miller A (1988). "Obstructive sleep apnea in syringomyelia-syringobulbia". N Y State J Med. 88 (3): 152–4. PMID 3357616.
  62. Klekamp J (2012). "Treatment of posttraumatic syringomyelia". J Neurosurg Spine. 17 (3): 199–211. doi:10.3171/2012.5.SPINE11904. PMID 22794351.
  63. Nagoshi N, Iwanami A, Toyama Y, Nakamura M (2014). "Factors contributing to improvement of syringomyelia after foramen magnum decompression for Chiari type I malformation". J Orthop Sci. 19 (3): 418–23. doi:10.1007/s00776-014-0555-x. PMID 24633622.
  64. Sgouros S, Williams B (1995). "A critical appraisal of drainage in syringomyelia". J Neurosurg. 82 (1): 1–10. doi:10.3171/jns.1995.82.1.0001. PMID 7815110.
  65. Koyanagi I, Iwasaki Y, Hida K, Houkin K (2005). "Clinical features and pathomechanisms of syringomyelia associated with spinal arachnoiditis". Surg Neurol. 63 (4): 350–5, discussion 355-6. PMID 15808720.
  66. Shannon N, Symon L, Logue V, Cull D, Kang J, Kendall B (1981). "Clinical features, investigation and treatment of post-traumatic syringomyelia". J Neurol Neurosurg Psychiatry. 44 (1): 35–42. PMC 490816. PMID 7205304.
  67. 67.0 67.1 67.2 67.3 67.4 Rene Hudson B, Cook C, Goode A (2008). "Identifying myelopathy caused by thoracic syringomyelia: a case report". J Man Manip Ther. 16 (2): 82–8. doi:10.1179/106698108790818512. PMC 2565119. PMID 19119392.
  68. Kim HG, Oh HS, Kim TW, Park KH (2014). "Clinical Features of Post-Traumatic Syringomyelia". Korean J Neurotrauma. 10 (2): 66–9. doi:10.13004/kjnt.2014.10.2.66. PMC 4852605. PMID 27169036.
  69. Jones J, Wolf S (1998). "Neuropathic shoulder arthropathy (Charcot joint) associated with syringomyelia". Neurology. 50 (3): 825–7. PMID 9521293.
  70. Schurch B, Wichmann W, Rossier AB (1996). "Post-traumatic syringomyelia (cystic myelopathy): a prospective study of 449 patients with spinal cord injury". J Neurol Neurosurg Psychiatry. 60 (1): 61–7. PMC 486191. PMID 8558154.
  71. Janicki JA, Alman B (2007). "Scoliosis: Review of diagnosis and treatment". Paediatr Child Health. 12 (9): 771–6. PMC 2532872. PMID 19030463.
  72. Kuruvilla A (2000). "Syringomyelia and respiratory failure". Lancet. 356 (9241): 1609. doi:10.1016/S0140-6736(05)74457-3. PMID 11075799.
  73. Bullock R, Todd NV, Easton J, Hadley D (1988). "Isolated central respiratory failure due to syringomyelia and Arnold-Chiari malformation". BMJ. 297 (6661): 1448–9. PMC 1835174. PMID 3147011.
  74. Viswanatha B (2009). "Syringomyelia with syringobulbia presenting as vocal fold paralysis". Ear Nose Throat J. 88 (7): E20. PMID 19623519.
  75. Nacir B, Arslan Cebeci S, Cetinkaya E, Karagoz A, Erdem HR (2010). "Neuropathic arthropathy progressing with multiple joint involvement in the upper extremity due to syringomyelia and type I Arnold-Chiari malformation". Rheumatol Int. 30 (7): 979–83. doi:10.1007/s00296-009-1013-5. PMID 19547980.
  76. Cardoso M, Keating RF (2009). "Neurosurgical management of spinal dysraphism and neurogenic scoliosis". Spine (Phila Pa 1976). 34 (17): 1775–82. doi:10.1097/BRS.0b013e3181b07914. PMID 19602995.
  77. 77.0 77.1 Dowling RJ, Tress BM (1989). "MRI--the investigation of choice in syringomyelia?". Australas Radiol. 33 (4): 337–43. PMID 2633734.
  78. Bogdanov EI, Ibatullin MM, Mendelevich EG (2000). "Spontaneous drainage in syringomyelia: magnetic resonance imaging findings". Neuroradiology. 42 (9): 676–8. PMID 11071442.
  79. Terae S, Hida K, Sasaki H (2011). "[Diagnosis of syringomyelia and its classification on the basis of symptoms, radiological appearance, and causative disorders]". Brain Nerve. 63 (9): 969–77. PMID 21878699.
  80. Hofkes SK, Iskandar BJ, Turski PA, Gentry LR, McCue JB, Haughton VM (2007). "Differentiation between symptomatic Chiari I malformation and asymptomatic tonsilar ectopia by using cerebrospinal fluid flow imaging: initial estimate of imaging accuracy". Radiology. 245 (2): 532–40. doi:10.1148/radiol.2452061096. PMID 17890352.
  81. Tanghe HL (1995). "Magnetic resonance imaging (MRI) in syringomyelia". Acta Neurochir (Wien). 134 (1–2): 93–9. PMID 7668137.
  82. Aichner F, Poewe W, Rogalsky W, Wallnöfer K, Willeit J, Gerstenbrand F (1985). "Magnetic resonance imaging in the diagnosis of spinal cord diseases". J Neurol Neurosurg Psychiatry. 48 (12): 1220–9. PMC 1028605. PMID 3936900.
  83. Timpone VM, Patel SH (2015). "MRI of a syrinx: is contrast material always necessary?". AJR Am J Roentgenol. 204 (5): 1082–5. doi:10.2214/AJR.14.13310. PMID 25905945.
  84. Wang GP (1989). "[Diagnostic value of delayed enhancement CT scan for syringomyelia]". Zhonghua Shen Jing Jing Shen Ke Za Zhi. 22 (4): 225–8, 253. PMID 2620591.
  85. Toriyama T, Kawauchi M, Koike J, Harada T, Murata A, Kyoshima K (1991). "[A case of disproportionately large communicating fourth ventricle (DLCFV) combined with syringomyelia and Chiari malformation]". No Shinkei Geka. 19 (2): 167–72. PMID 2023674.
  86. Simmons JD, Norman D, Newton TH (1983). "Preoperative demonstration of postinflammatory syringomyelia". AJNR Am J Neuroradiol. 4 (3): 625–8. PMID 6410816.
  87. 87.0 87.1 La Haye PA, Batzdorf U (1988). "Posttraumatic syringomyelia". West J Med. 148 (6): 657–63. PMC 1026203. PMID 3176472.
  88. Li KC, Chui MC (1987). "Conventional and CT metrizamide myelography in Arnold-Chiari I malformation and syringomyelia". AJNR Am J Neuroradiol. 8 (1): 11–7. PMID 3101451.
  89. Nogués MA, Stålberg E (1999). "Electrodiagnostic findings in syringomyelia". Muscle Nerve. 22 (12): 1653–9. PMID 10567077.
  90. Schwartz MS, Stålberg E, Swash M (1980). "Pattern of segmental motor involvement in syringomyelia: a single fibre EMG study". J Neurol Neurosurg Psychiatry. 43 (2): 150–5. PMC 490490. PMID 7359152.
  91. Milhorat TH, Kotzen RM, Mu HT, Capocelli AL, Milhorat RH (1996). "Dysesthetic pain in patients with syringomyelia". Neurosurgery. 38 (5): 940–6, discussion 946-7. PMID 8727819.
  92. Zuev AA, Pedyash NV, Epifanov DS, Kostenko GV (2016). "[Results of surgical treatment of syringomyelia associated with Chiari 1 malformation. An analysis of 125 cases]". Zh Vopr Neirokhir Im N N Burdenko. 80 (1): 27–34. PMID 27029329.
  93. 93.0 93.1 Mueller D, Oro' JJ (2005). "Prospective analysis of self-perceived quality of life before and after posterior fossa decompression in 112 patients with Chiari malformation with or without syringomyelia". Neurosurg Focus. 18 (2): ECP2. PMID 15715455.
  94. Milhorat TH, Johnson WD, Miller JI, Bergland RM, Hollenberg-Sher J (1992). "Surgical treatment of syringomyelia based on magnetic resonance imaging criteria". Neurosurgery. 31 (2): 231–44, discussion 244-5. PMID 1513429.
  95. Frazier CH, Rowe SN (1936). "THE SURGICAL TREATMENT OF SYRINGOMYELIA". Ann Surg. 103 (4): 481–97. PMC 1391054. PMID 17856740.
  96. 96.0 96.1 Batzdorf U, McArthur DL, Bentson JR (2013). "Surgical treatment of Chiari malformation with and without syringomyelia: experience with 177 adult patients". J Neurosurg. 118 (2): 232–42. doi:10.3171/2012.10.JNS12305. PMID 23176335.
  97. 97.0 97.1 Iwasaki Y, Hida K, Koyanagi I, Kuroda S, Abe H (1995). "[Surgical treatment for syringomyelia associated with Chiari malformation]". Rinsho Shinkeigaku. 35 (12): 1409–11. PMID 8752413.
  98. Galarza M, Gazzeri R, Alfieri A, Martínez-Lage JF (2013). ""Triple R" tonsillar technique for the management of adult Chiari I malformation: surgical note". Acta Neurochir (Wien). 155 (7): 1195–201. doi:10.1007/s00701-013-1749-2. PMID 23695377.
  99. Bao C, Yang F, Liu L, Wang B, Li D, Gu Y; et al. (2013). "Surgical treatment of Chiari I malformation complicated with syringomyelia". Exp Ther Med. 5 (1): 333–337. doi:10.3892/etm.2012.784. PMC 3524293. PMID 23251294.
  100. Barbaro NM, Wilson CB, Gutin PH, Edwards MS (1984). "Surgical treatment of syringomyelia. Favorable results with syringoperitoneal shunting". J Neurosurg. 61 (3): 531–8. doi:10.3171/jns.1984.61.3.0531. PMID 6747690.
  101. Williams B, Page N (1987). "Surgical treatment of syringomyelia with syringopleural shunting". Br J Neurosurg. 1 (1): 63–80. PMID 3267280.
  102. Fox B, Muzumdar D, DeMonte F (2005). "Resolution of tonsillar herniation and cervical syringomyelia following resection of a large petrous meningioma: case report and review of literature". Skull Base. 15 (1): 89–97, discussion 98. doi:10.1055/s-2005-868168. PMC 1151707. PMID 16148987.
  103. Buxton N, Jaspan T, Punt J (2002). "Treatment of Chiari malformation, syringomyelia and hydrocephalus by neuroendoscopic third ventriculostomy". Minim Invasive Neurosurg. 45 (4): 231–4. doi:10.1055/s-2002-36195. PMID 12494359.
  104. Deng K, Li YN, Li GL, Gao J, Yang Z, Di X; et al. (2010). "Neural endoscopic assisted micro-invasive management of Chiari I malformation". Chin Med J (Engl). 123 (14): 1878–83. PMID 20819571.
  105. Métellus P, Dufour H, Levrier O, Grisoli F (2002). "Endoscopic third ventriculostomy for treatment of noncommunicating syringomyelia associated with a Chiari I malformation and hydrocephalus: case report and pathophysiological considerations". Neurosurgery. 51 (2): 500–3, discussion 503-4. PMID 12182791.